Difference between revisions of "Team:Jilin China/Construction"
| Line 75: | Line 75: | ||
<p>CONSTRUCTION</p> | <p>CONSTRUCTION</p> | ||
<br /> | <br /> | ||
| − | <table> | + | <!--table> |
<tr> | <tr> | ||
<td><a href="#paragraph_1" class="clickwave">Protolols</a></td> | <td><a href="#paragraph_1" class="clickwave">Protolols</a></td> | ||
| Line 83: | Line 83: | ||
</tr> | </tr> | ||
| − | </table> | + | </table--> |
</div> | </div> | ||
Revision as of 13:33, 28 September 2018
CONSTRUCTION
Construction
-
Title 1
-
References
- Dai H, Wang Y, Lu X, et al. Chimeric antigen receptors modified T-cells for cancer therapy[J]. JNCI: Journal of the National Cancer Institute, 2016, 108(7).
- aaaaaa
- aaaaaa